My Authors
Read all threads
We've seen a lot of encouraging clinical trial results for repurposed drugs, re-directed against #COVID19, in just 2 weeks. 4 different pathways. Potential for combinations. That's why I'm optimistic.
R=randomized.
Beyond repurposing drugs, and convalescent plasma, the monoclonal, neutralizing antibodies (nAbs) are moving fast in clinical trials and I think they have particular promise, relevant links here
That's why I said to @bfrist in a podcast this week that I think the fatality rate for #COVID19 will come down before the end of the year
It's going to take combinations (remember the #HIV story) to get strong efficacy vs #SARSCoV2
And @joewalkerWSJ gets into that today
wsj.com/articles/gilea…
Missing some Tweet in this thread? You can try to force a refresh.

Enjoying this thread?

Keep Current with Eric Topol

Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

Twitter may remove this content at anytime, convert it as a PDF, save and print for later use!

Try unrolling a thread yourself!

how to unroll video

1) Follow Thread Reader App on Twitter so you can easily mention us!

2) Go to a Twitter thread (series of Tweets by the same owner) and mention us with a keyword "unroll" @threadreaderapp unroll

You can practice here first or read more on our help page!

Follow Us on Twitter!

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!